Quark to Present at JPMorgan 26th Annual Healthcare Conference
Preclinical Developments to be Highlighted: Delivery of siRNA to Bone Marrow and Proof of Concept Study Results –
Fremont, California, December 20, 2007 – Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company engaged in discovering and developing novel therapeutic RNAi drug candidates, announced today that it is scheduled to present at the JPMorgan 26th Annual Healthcare Conference on […]